Intravenous pamidronate treatment in osteogenesis imperfecta

被引:86
作者
Bembi, B
Parma, A
Bottega, M
Ceschel, S
Zanatta, M
Martini, C
Ciana, G
机构
[1] OSPED CIVILE, TERZA DIV MED, TRIESTE, ITALY
[2] CARATERE SCI BURLO GAROFOLO, IST RICERCA & CURA, IST CLIN PEDIAT, TRIESTE, ITALY
关键词
D O I
10.1016/S0022-3476(97)70074-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Three children with osteogenesis imperfecta, severe osteopenia, and repeated fractures were treated with cyclic infusions of aminohydroxypropylidene bisphosphonate (pamidronate) for a period ranging from 22 to 29 months. A clear clinical response was shown, with a striking reduction of new fracture episodes and a marked improvement in the quality of the patients' lives. Bone mineral density increased significantly in two patients, and linear growth continued along the percentile at the start of treatment. There were no adverse effects of note during treatment, and further studies are warranted.
引用
收藏
页码:622 / 625
页数:4
相关论文
共 20 条
[11]   CHARACTERISTICS AND BISPHOSPHONATE TREATMENT OF A PATIENT WITH JUVENILE OSTEOPOROSIS [J].
HOEKMAN, K ;
PAPAPOULOS, SE ;
PETERS, ACB ;
BIJVOET, OLM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (05) :952-956
[12]   CLINICAL AND ANTHROPOMETRIC CORRELATES OF BONE-MINERAL ACQUISITION IN HEALTHY ADOLESCENT GIRLS [J].
KATZMAN, DK ;
BACHRACH, LK ;
CARTER, DR ;
MARCUS, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (06) :1332-1339
[13]   EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS [J].
LIBERMAN, UA ;
WEISS, SR ;
BROLL, J ;
MINNE, HW ;
QUAN, H ;
BELL, NH ;
RODRIGUEZPORTALES, J ;
DOWNS, RW ;
DEQUEKER, J ;
FAVUS, M ;
SEEMAN, E ;
RECKER, RR ;
CAPIZZI, T ;
SANTORA, AC ;
LOMBARDI, A ;
SHAH, RV ;
HIRSCH, LJ ;
KARPF, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1437-1443
[14]  
PAPAPOULOS SE, 1994, BONE MINER S, V25, pS74
[15]  
SAMUEL R, 1994, PEDIATRICS, V94, P385
[16]   OSTEOPENIA IN CEREBRAL-PALSY [J].
SHAW, NJ ;
WHITE, CP ;
FRASER, WD ;
ROSENBLOOM, L .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 71 (03) :235-238
[17]   GENETIC-HETEROGENEITY IN OSTEOGENESIS IMPERFECTA [J].
SILLENCE, DO ;
SENN, A ;
DANKS, DM .
JOURNAL OF MEDICAL GENETICS, 1979, 16 (02) :101-116
[18]   EFFECT OF INTERMITTENT CYCLICAL ETIDRONATE THERAPY ON BONE MASS AND FRACTURE RATE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS [J].
STORM, T ;
THAMSBORG, G ;
STEINICHE, T ;
GENANT, HK ;
SORENSEN, OH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1265-1271
[19]  
VANMEERTEN ELV, 1992, RADIOLOGY, V184, P249
[20]   BONE-MINERAL DENSITY IN CHILDREN WITH MILD OSTEOGENESIS IMPERFECTA [J].
ZIONTS, LE ;
NASH, JP ;
RUDE, R ;
ROSS, T ;
STOTT, NS .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1995, 77B (01) :143-147